
WuXi STA
Changzhou, China sta.wuxiapptec.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
WuXi STA provides contract development and manufacturing services for small-molecule and synthetic-molecule pharmaceuticals. It serves clients globally from facilities across Asia, North America, and Europe, supporting projects from preclinical through commercial stages.
Services
API process development
Develops synthetic routes and process R&D for starting materials, intermediates, and active pharmaceutical ingredients from preclinical to commercial launch.
API manufacturing
Manufactures small-molecule intermediates, building blocks, and drug substance from gram to metric-ton scale.
High potency API
Provides process R&D and manufacturing for high-potency APIs, including facilities handling HP compounds with an OEL of 10 ng/m3.
Flow chemistry
Offers process development, non-GMP, and GMP production services using continuous manufacturing flow chemistry.
Biocatalysis
Uses enzyme-based biocatalysis for stereoselective biotransformations and enantiomer resolutions.
Drug product oral solid development
Supports pre-formulation, formulation development, and manufacturing for oral solid dosage forms.
Pre-formulation
Studies physicochemical properties to support selection of developable molecules at the preclinical stage.
Formulation development
Develops oral solid formulations from preclinical to commercial manufacturing.
Oral solid state development
Characterizes solid-state properties of APIs and drug products for oral solid dosage development.
Drug product parenteral development
Provides pre-formulation, formulation, and analytical support for parenteral projects from preclinical studies through commercial launch.
Parenteral manufacturing
Manufactures injectable drug products at scale for various dosage forms and filling formats.
Clinical supply service
Provides clinical trial materials from Phase I to Phase IV through an integrated CMC platform.
Analytical development and quality control
Provides analytical method development, validation, testing, quality control, and stability studies for drug substance and drug product programs.
Regulatory CMC dossier preparation
Prepares CMC dossiers to support global regulatory filings.
Spray dried dispersion
Provides spray-dried dispersion capabilities from laboratory to production scale.
Process Development
Provides API process development for synthetic drugs from preclinical to clinical and commercial launch, including starting materials, intermediates, and API.
Manufacturing
Manufactures starting material, intermediate, and drug substance within a global supply chain network.
CDMO: development & manufacturing
Preparative HPLC, SFC, and SMB
Uses preparative HPLC, supercritical fluid chromatography, and simulated moving bed chromatography as enabling technologies.
Crystallization and Particle Engineering
Provides crystallization and particle engineering support within the drug substance platform.
Drug Product Development
Provides formulation development and manufacturing from preclinical to commercial phase.
Parenteral Development
Supports parenteral dosage form development and manufacturing.
Lipid Nanoparticle Platform
Provides lipid nanoparticle capabilities from laboratory to production scale.
Hot Melt Extrusion
Offers hot melt extrusion as a bioavailability-enhancing technology.
Lipid Formulation
Provides lipid formulation development support.
Nano Suspension
Provides nanosuspension development support.
Reference Standard Characterization and Qualification
Provides reference standard characterization and qualification as part of analytical services.
Regulatory Dossier Preparation
Prepares CMC submission packages and regulatory dossiers for IND, IMPD, and NDA submissions.
- Lead time
- 6-8 weeks to prepare IND submission package for US FDA
- What to send
- Work Email · Company / Institution · Country / Region · First Name · Last Name · Job Title
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · Peptide · Oligonucleotide · LNP / formulation · LNP · Process development · Small molecules · HPLC · Peptides · Oligonucleotides · Analytical development · Stability studies
- Capacity
- Few grams to metric ton scale · OEL of 10 ng/m3 · 5 production lines · Total reactor volume exceeds 4,000 m3 · 6 sites in Asia and North America · 3,600+ process chemists and analytical scientists · 1,500+ formulators & analytical scientists · 3,500+ analytical scientists · OEL ≥10 ng/m³ · 2024: 1,000+ preclinical-phase III molecules supported · 50+ late-phase NCEs validated · 10+ commercial products supported
1 more
740+ CMC submission packages written during 2019-2024 - Scales
- Gram · Kilogram · Ton
- Data supplied
- HPLC
Equipment
- Prep-HPLC
- SFC
- SMB
- Spray dryers
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CRDMO
- Team
- 3,600+ process chemists and analytical scientists; 1,500+ formulators & analytical scientists; 3,500+ analytical scientists
Locations
- Address
- Manufacturing 20+ years' experience Over 20 years of experience in API manuf
- Sites
- Shanghai Waigaoqiao, China · Shanghai, China · Wuxi City, China · Taixing, China · Changzhou, China · Jinshan, China · Tuas, Singapore · Middletown, Delaware, USA · San Diego, California, USA · Couvet, Neuchâtel, Switzerland · Shanghai Jinshan, China
- Serves
- globally, Asia, North America, Europe, 105 countries, worldwide
Similar labs
Work here? Claim this listing